- Home
- ASPN vs KALV Comparison
ASPN vs KALV Comparison
Compare ASPN & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPN
- KALV
- Stock Information
- Founded
- ASPN 2001
- KALV N/A
- Country
- ASPN United States
- KALV United States
- Employees
- ASPN N/A
- KALV N/A
- Industry
- ASPN RETAIL: Building Materials
- KALV Biotechnology: Pharmaceutical Preparations
- Sector
- ASPN Consumer Discretionary
- KALV Health Care
- Exchange
- ASPN Nasdaq
- KALV Nasdaq
- Market Cap
- ASPN 570.6M
- KALV 563.1M
- IPO Year
- ASPN 2014
- KALV N/A
- Fundamental
- Price
- ASPN $5.44
- KALV $10.52
- Analyst Decision
- ASPN Strong Buy
- KALV Strong Buy
- Analyst Count
- ASPN 11
- KALV 8
- Target Price
- ASPN $23.20
- KALV $24.83
- AVG Volume (30 Days)
- ASPN 1.4M
- KALV 599.5K
- Earning Date
- ASPN 04-30-2025
- KALV 03-12-2025
- Dividend Yield
- ASPN N/A
- KALV N/A
- EPS Growth
- ASPN N/A
- KALV N/A
- EPS
- ASPN 0.17
- KALV N/A
- Revenue
- ASPN $452,699,000.00
- KALV N/A
- Revenue This Year
- ASPN N/A
- KALV N/A
- Revenue Next Year
- ASPN $35.45
- KALV N/A
- P/E Ratio
- ASPN $33.06
- KALV N/A
- Revenue Growth
- ASPN 89.64
- KALV N/A
- 52 Week Low
- ASPN $5.46
- KALV $7.30
- 52 Week High
- ASPN $33.15
- KALV $15.50
- Technical
- Relative Strength Index (RSI)
- ASPN 21.25
- KALV 42.59
- Support Level
- ASPN $6.23
- KALV $10.55
- Resistance Level
- ASPN $6.48
- KALV $11.78
- Average True Range (ATR)
- ASPN 0.35
- KALV 0.60
- MACD
- ASPN -0.06
- KALV -0.23
- Stochastic Oscillator
- ASPN 2.68
- KALV 20.20
About ASPN Aspen Aerogels Inc.
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Energy Industrial segment and the United States market. Some of its products include Pyrogel XTE; Cryogel Z; Spaceloft Subsea; and others.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.